STERIS Announces New Extractables and Leachables Service Offering Featuring Advanced Chemical Analysis Laboratory

28. März 2025

  • Supports medical device and pharmaceutical manufacturing with additional testing and service capacity
  • Provides a comprehensive suite of testing options for the validation of sterile medical devices and pharmaceuticals

As part of our long-term commitment to supporting medical device and pharmaceutical manufacturing, STERIS Applied Sterilization Technologies (AST) is pleased to announce the addition of Extractables and Leachables (E&L) testing, featuring advanced chemical analysis. The additional testing capabilities are performed in accordance with ISO 10993-18 for chemical characterization, ensuring comprehensive safety and compliance for medical devices and pharmaceuticals.

Our chemical analysis testing services includes:

  • Extractables and leachables testing: Identification and quantification of potential leachable substances
  • Cytotoxicity testing: Evaluation of medical device materials to ensure they do not release toxic substances that could inhibit cell growth or induce cell death upon contact with the human body
  • Method development and validation: Development and validation of Customer-specific biocompatibility test methods for application
  • TechTeam® technical professional guidance: Tailored guidance on biocompatibility test requirements specific to Customer product, ensuring compliance with industry standards
  • Investigation of unexpected results: Support for chemical root cause analysis and countermeasure development to achieve desired results

Within these services, our chemical analysis testing includes a variety of analytical tests, including, but not limited to:

Test Type Method/Technique
Elemental analysis Inductively Coupled Plasma Mass Spectrometry (ICP-MS)
Identification Fourier Transform Infrared Spectroscopy (FTIR)
TOC analysis Total Organic Carbon (TOC)
Microscopic evaluation / particulate analysis <USP 788> Digital microscope
Melting point / glass transition Differential Scanning Calorimetry (DSC)
Ion content Ion Chromatography (IC)

In addition to these services, STERIS AST also offers wastewater analysis, supporting the safety and compliance of wastewater processing and recycling systems; testing performed in accordance with ISO 10304 and ISO 17294.

Our testing methods adhere to both USP (United States Pharmacopeia) and EP (European Pharmacopoeia) standards, ensuring that our services meet the highest international quality and regulatory requirements.

For more information about our new E&L service offering and advanced chemical analysis, please contact us.

Über STERIS

STERIS ist ein weltweit führender Anbieter von Produkten und Dienstleistungen zur Unterstützung der Patientenversorgung mit Schwerpunkt auf Infektionsprävention. 

WIR HELFEN UNSEREN KUNDEN, EINE GESÜNDERE UND SICHERE WELT ZU SCHAFFEN, indem wir weltweit innovative Produkte und Dienstleistungen für das Gesundheitswesen und die Biowissenschaften anbieten. 

Weitere Informationen finden Sie unter www.steris.com.

 
Related Posts
STERIS gibt Fertigstellung des Werks in Suzhou, China, bekannt, das nun auch eine Röntgenverarbeitung umfasst
22. August 2025

Im Rahmen seines langfristigen Engagements zur Unterstützung der globalen Medizinprodukteherstellung freut sich STERIS, die Fertigstellung der Erweiterung seines bestehenden EO-Verarbeitungswerks in Suzhou, China, um die Röntgenstrahlenverarbeitung bekannt zu geben.